Cairo University Hospital
Cairo, 11559, Egypt
NCT Number: NCT04354792
To assess the seroprevalence of SARS-CoV-2 IgG in Health care workers in three University Hospitals
Looking for future studies?
Notify Me25 year–60 year
All sexes
Observational
Cairo, 11559, Egypt
The proposed study is a cross sectional study that will be carried out among HCWs in three University hospitals namely Kasr Alaini , Ain Shams , and Zagazeg Hospitals, employing a quantitative survey.
II-Study population Participants will be the HCWs at great risk of getting an infection which include those who are in direct contact with respiratory secretions.
Inclusion criteria
Age: From 25 to 60 years old Department: physicians and nurses from the operating room, critical care department, emergency department, pulmonology department.
The potential participants will be given an information sheet and time to review this information before informed consent is sought. After the potential participants have agreed to be enrolled in the study, an informed consent will be obtained by the Investigator.
III- Procedures and Data collection:
Serum Collection and Interview A- Detecting Serum IgG against SARS-CoV2
Blood samples will be collected from the enrolled HCWs. Sample collection, processing, and laboratory testing will follow guidance from the World Health Organization.(5) The sensitivity and specificity reported by the manufacturer for IgM are 88.2% and 99.0% respectively, and for IgG are 97.8% and 97.9%.
B- Structured Interview questionnaire
A structured - interview questionnaire using closed ended question format will be used to obtain information on:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Blood samples will be collected from the enrolled HCWs. Sample collection, processing, and laboratory testing will follow guidance from the World Health Organization
Time frame: single measurement from each person collected over 2 months
health care workers who have positive IGg in seum
Time frame: 2 months through out duration of study
to know positive IGg persons and IGg negative persons to understand risk factors
Kasr El Aini Hospital
Other
Asymptomatic SARS- CoV2 Infection Among Healthcare Workers in Three University Hospitals: A Cross Sectional Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04768621
Depressive Disorder, Endocrine System Diseases
Saint-Denis, Reunion
View Trial DetailsNCT03134768
Immunologic Activity Alteration
View Trial DetailsNCT03796949
Female Urogenital Diseases and Pregnancy Complications, Immunologic Activity Alteration
View Trial DetailsNCT06580639
Actinomycetales Infections, Bacterial Infections
Kalmar, Sweden
View Trial Details